WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses 01/04/2024 Maayan Hoffman The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging coronaviruses that pose significant public health risks. The program expands on the WHO COVID-19 reference laboratory network, established in January 2020, in the early days of the pandemic. Originally, the network’s primary goal was […] Continue reading -> Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> COVID Vaccines in European Region Reduced Mortality by 57%; WHO Warns of Waning Vigilance Regarding Virus Threats 16/01/2024 Elaine Ruth Fletcher COVID-19 vaccines reduced deaths due to the pandemic by at least 57%, saving more than 1.4 million lives in the WHO European Region between December 2020 and March 2023, according to a report published in medRxiv, a pre-print platform for health sciences, on Tuesday. Most of the lives saved were those of people aged 60 […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity 21/03/2024 Elaine Ruth Fletcher Pharmaceutical giants could support a formula whereby companies are guaranteed free and immediate access to pathogens with pandemic potential in exchange for binding equity agreements as part of a proposed World Health Organization (WHO) pandemic agreement, says a leading industry figure. The statement by Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers […] Continue reading -> New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> COVID Vaccines in European Region Reduced Mortality by 57%; WHO Warns of Waning Vigilance Regarding Virus Threats 16/01/2024 Elaine Ruth Fletcher COVID-19 vaccines reduced deaths due to the pandemic by at least 57%, saving more than 1.4 million lives in the WHO European Region between December 2020 and March 2023, according to a report published in medRxiv, a pre-print platform for health sciences, on Tuesday. Most of the lives saved were those of people aged 60 […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Research Reveals High Prevalence of Persistent COVID Infections 26/02/2024 Maayan Hoffman A much higher percentage of the population has experienced “persistent” COVID-19 infections lasting more than 30 days than initially assumed, according to new research by the University of Oxford. The study, published on February 21 in Nature, found that one to three of every 100 infections may last a month or longer. The scientists, using […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> COVID Vaccines in European Region Reduced Mortality by 57%; WHO Warns of Waning Vigilance Regarding Virus Threats 16/01/2024 Elaine Ruth Fletcher COVID-19 vaccines reduced deaths due to the pandemic by at least 57%, saving more than 1.4 million lives in the WHO European Region between December 2020 and March 2023, according to a report published in medRxiv, a pre-print platform for health sciences, on Tuesday. Most of the lives saved were those of people aged 60 […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> COVID Vaccines in European Region Reduced Mortality by 57%; WHO Warns of Waning Vigilance Regarding Virus Threats 16/01/2024 Elaine Ruth Fletcher COVID-19 vaccines reduced deaths due to the pandemic by at least 57%, saving more than 1.4 million lives in the WHO European Region between December 2020 and March 2023, according to a report published in medRxiv, a pre-print platform for health sciences, on Tuesday. Most of the lives saved were those of people aged 60 […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Vaccines in European Region Reduced Mortality by 57%; WHO Warns of Waning Vigilance Regarding Virus Threats 16/01/2024 Elaine Ruth Fletcher COVID-19 vaccines reduced deaths due to the pandemic by at least 57%, saving more than 1.4 million lives in the WHO European Region between December 2020 and March 2023, according to a report published in medRxiv, a pre-print platform for health sciences, on Tuesday. Most of the lives saved were those of people aged 60 […] Continue reading -> WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Secures First COVID-19 Vaccine Licence from Private Pharmaceutical Company 31/08/2023 Stefan Anderson Three years after the launch of its COVID-19 Technology Access Pool (C-TAP) initiative, the World Health Organization (WHO) has secured its first COVID-19 vaccine license from a private pharmaceutical company, the UN health body announced on Tuesday. The agreement with Medigen Vaccine Biologics Corp., a private vaccine manufacturer based in Taiwan, is a welcome but underwhelming […] Continue reading -> Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Data Gap Grows As Countries Stop Reporting to WHO 25/08/2023 Stefan Anderson Fewer than 20 countries worldwide still report COVID-19 hospitalization and ICU data to the World Health Organization (WHO), leaving the UN health body blind to the impact and evolution of the virus in most of the world, agency leaders said Friday. The decline in data reporting is a major setback for the WHO’s efforts to […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Virus ‘Superspreaders’: No Link to Severity of COVID-19 Symptoms 28/06/2023 Stefan Anderson Since the beginning of the SARS-CoV-2 pandemic, the popular assumption was that people displaying severe symptons were also the most contagious. But new data from a controversial Imperial College London study published on Tuesday found the two participants that were the biggest “superspreaders” of the virus both displayed only minor symptoms. “How symptomatic a person […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older posts